Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry
- 1.5k Downloads
Carfentanil is an ultra-potent synthetic opioid. No human carfentanil metabolism data are available. Reportedly, Russian police forces used carfentanil and remifentanil to resolve a hostage situation in Moscow in 2002. This alleged use prompted interest in the pharmacology and toxicology of carfentanil in humans. Our study was conducted to identify human carfentanil metabolites and to assess carfentanil’s metabolic clearance, which could contribute to its acute toxicity in humans. We used Simulations Plus’s ADMET Predictor™ and Molecular Discovery’s MetaSite™ to predict possible metabolite formation. Both programs gave similar results that were generally good but did not capture all metabolites seen in vitro. We incubated carfentanil with human hepatocytes for up to 1 h and analyzed samples on a Sciex 3200 QTRAP mass spectrometer to measure parent compound depletion and extrapolated that to represent intrinsic clearance. Pooled primary human hepatocytes were then incubated with carfentanil up to 6 h and analyzed for metabolite identification on a Sciex 5600+ TripleTOF (QTOF) high-resolution mass spectrometer. MS and MS/MS analyses elucidated the structures of the most abundant metabolites. Twelve metabolites were identified in total. N-Dealkylation and monohydroxylation of the piperidine ring were the dominant metabolic pathways. Two N-oxide metabolites and one glucuronide metabolite were observed. Surprisingly, ester hydrolysis was not a major metabolic pathway for carfentanil. While the human liver microsomal system demonstrated rapid clearance by CYP enzymes, the hepatocyte incubations showed much slower clearance, possibly providing some insight into the long duration of carfentanil’s effects.
KEY WORDScarfentanil metabolism norcarfentanil opioid
The authors would like to acknowledge Drs. Alison Director-Myska, Eric Moore, Neil Jensen, and Joseph Corriveau for their unwavering and continued support of this research effort. We would also like to acknowledge Simulations Plus and Molecular Discovery for the use of their software for the in silico metabolite predictions. Finally, we would like to acknowledge Tim Moeller of BioreclamationIVT for his help with the primary hepatocyte culturing procedures and technical support.
This work was funded by the Defense Threat Reduction Agency (DTRA) under project number CB3281.
- 9.Krechetnkiov A. Moscow theatre siege: questions remain unanswered. British Broadcasting Corporation. 24 October 2012. Web. 13 May 2015.Google Scholar
- 10.Glasser SB, Baker P. Russia confirms suspicions about gas used in raid; Potent Anesthetic Pumped Into Theater; 2 More Hostages Die From Drug’s Effects. The Washington Post 31 October 2002: A15. Print.Google Scholar
- 16.ULTIVA® (remifentanil hydrochloride) [package insert]. Rockford, IL, USA; Mylan Institutional LLC; Published March 2015. http://www.mylan.com/en/products/product-catalog/product-profile-page?id=DA2E7ACD-ADCF-4DC1-A9F9-8ECBE954909B. Accessed 1 June 2015.
- 18.Van Nimmen NF, Poels KL, Veulemans HA. Highly sensitive gas chromatographic-mass spectrometric screening method for the determination of picogram levels of fentanyl, sufentanil and alfentanil and their major metabolites in urine of opioid exposed workers. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;804(2):375–87.CrossRefPubMedGoogle Scholar
- 23.Allen JL. Renarcotization following Carfentanil immobilization of nondomestic ungulates. J Zoo Wildl Med. 1989;20(4):423–6.Google Scholar
- 24.Thevis M, Geyer H, Bahr D, Schänzer W. Identification of fentanyl, alfentanil, sufentanil, remifentanil and their major metabolites in human urine by liquid chromatography/tandem mass spectrometry for doping control purposes. Eur J Mass Spectrom (Chichester, Eng). 2005;11(4):419–27.CrossRefGoogle Scholar
- 29.VCCLAB, Virtual Computational Chemistry Laboratory, http://www.vcclab.org; 2005.
- 30.Hansch C, Leo A. Exploring QSAR: hydrophobic, electronic, and steric constants. Vol. 2. ACS Publications. 1995.Google Scholar
- 31.ADMET Predictor v7.2.0001. Simulations Plus, Inc. 2015.Google Scholar
- 33.Dart RC. Medical toxicology 3rd Edition. Phildelphia: Lippincott Williams and Wilkins; 2004. p. 762.Google Scholar
- 35.Mahlke NS, Ziesenitz V, Mikus G, Skopp G. Quantitative low-volume assay for simultaneous determination of fentanyl, norfentanyl, and minor metabolites in human plasma and urine by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Int J Legal Med. 2014;128(5):771–8.CrossRefPubMedGoogle Scholar